Science Total Current Liabilities vs Other Stockholder Equity Analysis

SAIC Stock

USD 136.68 0.86 0.63%

Science Applications financial indicator trend analysis is much more than just breaking down Science Applications prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Science Applications is a good investment. Please check the relationship between Science Applications Total Current Liabilities and its Other Stockholder Equity accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Science Applications International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

Total Current Liabilities vs Other Stockholder Equity

Total Current Liabilities vs Other Stockholder Equity Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Science Applications Total Current Liabilities account and Other Stockholder Equity. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Science Applications' Total Current Liabilities and Other Stockholder Equity is -0.04. Overlapping area represents the amount of variation of Total Current Liabilities that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Science Applications International, assuming nothing else is changed. The correlation between historical values of Science Applications' Total Current Liabilities and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Current Liabilities of Science Applications International are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Total Current Liabilities i.e., Science Applications' Total Current Liabilities and Other Stockholder Equity go up and down completely randomly.

Correlation Coefficient

-0.04

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Total Current Liabilities

Total Current Liabilities is an item on Science Applications balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Science Applications International are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Other Stockholder Equity

Most indicators from Science Applications' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Science Applications current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Science Applications International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

The current year's Sales General And Administrative To Revenue is expected to grow to 0.02, whereas Selling General Administrative is forecasted to decline to about 234.2 M.

	2021	2022	2023	2024 (projected)
Interest Expense	105M	120M	138M	86.4M
Depreciation And Amortization	222M	164M	142M	119.3M

Interest Expense Depreciation And Amortization

Science Applications fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets
Common Stock Shares Outstanding		0.58	0.14	0.65	0.82	0.67	0.62	0.77	-0.38	0.83	0.22	0.91	0.02	0.23	0.91	0.94	0.1	0.08	0.27	0.31	0.0	0.49	0.51	0.97	0.4	-0.35
Total Assets	0.58		0.86	0.5	0.79	0.95	0.94	0.52	0.51	0.79	0.62	0.45	0.82	0.03	0.45	0.77	0.85	0.82	0.11	0.14	-0.05	0.98	0.91	0.65	0.4	0.55
Short Long Term Debt Total	0.14	0.86		0.09	0.46	0.7	0.78	0.31	0.84	0.42	0.78	0.08	0.93	-0.13	0.08	0.4	0.92	0.99	-0.01	0.15	-0.08	0.92	0.77	0.25	0.21	0.85
Other Current Liab	0.65	0.5	0.09		0.82	0.58	0.43	0.16	-0.25	0.64	-0.3	0.61	0.15	0.24	0.61	0.67	0.23	-0.01	0.28	0.01	0.03	0.43	0.41	0.67	0.75	-0.13
Total Current Liabilities	0.82	0.79	0.46	0.82		0.76	0.78	0.61	-0.04	0.77	0.25	0.82	0.36	0.11	0.82	0.91	0.42	0.35	0.3	0.25	-0.04	0.76	0.7	0.89	0.77	0.04
Total Stockholder Equity	0.67	0.95	0.7	0.58	0.76		0.88	0.49	0.35	0.87	0.48	0.48	0.72	0.11	0.48	0.82	0.78	0.68	0.13	0.03	-0.01	0.87	0.87	0.69	0.29	0.41
Property Plant And Equipment Net	0.62	0.94	0.78	0.43	0.78	0.88		0.66	0.42	0.76	0.66	0.49	0.73	-0.07	0.49	0.76	0.75	0.75	0.13	0.08	-0.05	0.93	0.94	0.66	0.38	0.46
Current Deferred Revenue	0.77	0.52	0.31	0.16	0.61	0.49	0.66		-0.12	0.64	0.59	0.73	0.11	0.04	0.73	0.73	0.14	0.29	0.07	0.46	-0.16	0.52	0.59	0.76	0.21	-0.17
Net Debt	-0.38	0.51	0.84	-0.25	-0.04	0.35	0.42	-0.12		0.02	0.58	-0.46	0.89	-0.25	-0.46	-0.12	0.85	0.88	-0.11	-0.08	-0.1	0.58	0.48	-0.29	-0.12	0.99
Retained Earnings	0.83	0.79	0.42	0.64	0.77	0.87	0.76	0.64	0.02		0.29	0.6	0.42	0.33	0.6	0.83	0.51	0.4	-0.05	0.18	-0.15	0.7	0.77	0.77	0.32	0.05
Accounts Payable	0.22	0.62	0.78	-0.3	0.25	0.48	0.66	0.59	0.58	0.29		0.19	0.58	-0.19	0.19	0.38	0.55	0.8	-0.02	0.22	-0.03	0.68	0.57	0.3	-0.11	0.52
Cash	0.91	0.45	0.08	0.61	0.82	0.48	0.49	0.73	-0.46	0.6	0.19		-0.12	0.17	1.0	0.88	-0.06	-0.01	0.31	0.41	0.06	0.42	0.37	0.96	0.58	-0.42
Non Current Assets Total	0.02	0.82	0.93	0.15	0.36	0.72	0.73	0.11	0.89	0.42	0.58	-0.12		-0.14	-0.12	0.28	0.99	0.94	-0.02	-0.07	-0.11	0.84	0.77	0.1	0.12	0.92
Non Currrent Assets Other	0.23	0.03	-0.13	0.24	0.11	0.11	-0.07	0.04	-0.25	0.33	-0.19	0.17	-0.14		0.17	0.15	-0.09	-0.16	-0.52	0.13	0.02	-0.02	0.07	0.19	0.14	-0.23
Cash And Short Term Investments	0.91	0.45	0.08	0.61	0.82	0.48	0.49	0.73	-0.46	0.6	0.19	1.0	-0.12	0.17		0.88	-0.06	-0.01	0.31	0.41	0.06	0.42	0.37	0.96	0.58	-0.42
Net Receivables	0.94	0.77	0.4	0.67	0.91	0.82	0.76	0.73	-0.12	0.83	0.38	0.88	0.28	0.15	0.88		0.34	0.33	0.32	0.27	0.06	0.7	0.66	0.98	0.49	-0.08
Good Will	0.1	0.85	0.92	0.23	0.42	0.78	0.75	0.14	0.85	0.51	0.55	-0.06	0.99	-0.09	-0.06	0.34		0.93	-0.01	-0.05	-0.13	0.85	0.8	0.16	0.14	0.88
Non Current Liabilities Total	0.08	0.82	0.99	-0.01	0.35	0.68	0.75	0.29	0.88	0.4	0.8	-0.01	0.94	-0.16	-0.01	0.33	0.93		-0.02	0.11	-0.08	0.87	0.75	0.17	0.06	0.88
Inventory	0.27	0.11	-0.01	0.28	0.3	0.13	0.13	0.07	-0.11	-0.05	-0.02	0.31	-0.02	-0.52	0.31	0.32	-0.01	-0.02		0.11	-0.02	0.1	-0.12	0.3	0.16	-0.08
Other Current Assets	0.31	0.14	0.15	0.01	0.25	0.03	0.08	0.46	-0.08	0.18	0.22	0.41	-0.07	0.13	0.41	0.27	-0.05	0.11	0.11		-0.07	0.2	0.08	0.34	0.19	-0.14
Other Stockholder Equity	0.0	-0.05	-0.08	0.03	-0.04	-0.01	-0.05	-0.16	-0.1	-0.15	-0.03	0.06	-0.11	0.02	0.06	0.06	-0.13	-0.08	-0.02	-0.07		-0.07	-0.03	0.06	-0.06	-0.08
Total Liab	0.49	0.98	0.92	0.43	0.76	0.87	0.93	0.52	0.58	0.7	0.68	0.42	0.84	-0.02	0.42	0.7	0.85	0.87	0.1	0.2	-0.07		0.89	0.59	0.45	0.61
Property Plant And Equipment Gross	0.51	0.91	0.77	0.41	0.7	0.87	0.94	0.59	0.48	0.77	0.57	0.37	0.77	0.07	0.37	0.66	0.8	0.75	-0.12	0.08	-0.03	0.89		0.55	0.34	0.51
Total Current Assets	0.97	0.65	0.25	0.67	0.89	0.69	0.66	0.76	-0.29	0.77	0.3	0.96	0.1	0.19	0.96	0.98	0.16	0.17	0.3	0.34	0.06	0.59	0.55		0.53	-0.25
Short Term Debt	0.4	0.4	0.21	0.75	0.77	0.29	0.38	0.21	-0.12	0.32	-0.11	0.58	0.12	0.14	0.58	0.49	0.14	0.06	0.16	0.19	-0.06	0.45	0.34	0.53		-0.03
Intangible Assets	-0.35	0.55	0.85	-0.13	0.04	0.41	0.46	-0.17	0.99	0.05	0.52	-0.42	0.92	-0.23	-0.42	-0.08	0.88	0.88	-0.08	-0.14	-0.08	0.61	0.51	-0.25	-0.03

Click cells to compare fundamentals

Science Applications Account Relationship Matchups

Science Applications fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	59M	58.7M	58.1M	55.8M	53.7M	101.4M
Total Assets	4.7B	5.7B	5.7B	5.5B	5.3B	4.7B
Short Long Term Debt Total	2.1B	2.7B	2.7B	2.5B	2.2B	1.9B
Other Current Liab	203M	264M	309M	280M	514M	336.3M
Total Current Liabilities	1.1B	1.3B	1.4B	1.1B	1.2B	950.5M
Total Stockholder Equity	1.4B	1.5B	1.6B	1.7B	1.8B	1.4B
Property Plant And Equipment Net	281M	344M	309M	250M	243M	225.2M
Current Deferred Revenue	41M	82M	55M	48M	43.2M	51.9M
Net Debt	1.9B	2.5B	2.6B	2.4B	2.2B	1.4B
Retained Earnings	506M	627M	818M	1.0B	1.4B	1.5B
Accounts Payable	814M	861M	840M	767M	567M	688.4M
Cash	188M	171M	106M	109M	94M	89.3M
Non Current Assets Total	3.3B	4.4B	4.5B	4.3B	4.2B	2.8B
Non Currrent Assets Other	(153M)	(192M)	129M	(243M)	195M	204.8M
Cash And Short Term Investments	188M	171M	106M	109M	94M	89.3M
Net Receivables	1.1B	962M	1.0B	936M	914M	864.1M
Good Will	2.1B	2.8B	2.9B	2.9B	2.9B	1.9B
Liabilities And Stockholders Equity	4.7B	5.7B	5.7B	5.5B	5.3B	4.7B
Non Current Liabilities Total	2.2B	2.9B	2.8B	2.7B	2.4B	1.9B
Inventory	146M	143M	156M	142M	3M	2.9M
Other Current Assets	19M	22M	21M	23M	27M	21.3M
Other Stockholder Equity	984M	1.0B	(781M)	(1.1B)	337M	184.3M
Total Liab	3.3B	4.2B	4.1B	3.8B	3.5B	3.3B
Property Plant And Equipment Gross	281M	344M	309M	250M	427M	239.6M
Total Current Assets	1.4B	1.3B	1.3B	1.2B	1.1B	1.4B
Accumulated Other Comprehensive Income	(72M)	(89M)	(37M)	22M	16M	16.8M
Short Term Debt	70M	68M	148M	31M	77M	65.4M
Intangible Assets	711M	1.1B	1.1B	1.0B	894M	540.0M
Other Liab	102M	133M	244M	203M	233.5M	245.1M
Other Assets	100M	123M	138M	129M	148.4M	155.8M
Long Term Debt	1.9B	2.4B	2.4B	2.3B	2.0B	1.4B
Property Plant Equipment	91M	344M	309M	92M	105.8M	119.9M
Net Tangible Assets	(1.3B)	(2.4B)	(2.4B)	(2.1B)	(1.9B)	(2.0B)
Retained Earnings Total Equity	506M	627M	818M	1.0B	1.2B	1.2B
Long Term Debt Total	1.9B	2.4B	2.4B	2.3B	2.7B	1.7B
Capital Surpluse	983M	1.0B	838M	637M	732.6M	670.1M
Non Current Liabilities Other	133M	244M	160M	218M	174M	118.3M
Common Stock	1.5B	1.4B	1.6B	1.7B	1.9B	2.0B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
CRM	Salesforce
MSFT	Microsoft

When determining whether Science Applications offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Science Applications' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Science Applications International Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Science Applications International Stock:

How To Invest In Science

Details

Is Science Stock a good investment?

Details

What is Science Applications' Net Worth?

Details

Largest Information Technology Services Companies

View

Largest Information Technology Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Science Applications International. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.

You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for Science Stock analysis

When running Science Applications' price analysis, check to measure Science Applications' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Science Applications is operating at the current time. Most of Science Applications' value examination focuses on studying past and present price action to predict the probability of Science Applications' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Science Applications' price. Additionally, you may evaluate how the addition of Science Applications to your portfolios can decrease your overall portfolio volatility.

	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	CEOs Directory Screen CEOs from public companies around the world
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Stocks Directory Find actively traded stocks across global markets
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Volatility Analysis Get historical volatility and risk analysis based on latest market data

Is Science Applications' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Science Applications. If investors know Science will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Science Applications listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.45)

Dividend Share

1.48

Earnings Share

8.88

Revenue Per Share

140.188

Quarterly Revenue Growth

(0.12)

The market value of Science Applications is measured differently than its book value, which is the value of Science that is recorded on the company's balance sheet. Investors also form their own opinion of Science Applications' value that differs from its market value or its book value, called intrinsic value, which is Science Applications' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Science Applications' market value can be influenced by many factors that don't directly affect Science Applications' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Science Applications' value and its price as these two are different measures arrived at by different means. Investors typically determine if Science Applications is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Science Applications' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Science Total Current Liabilities vs Other Stockholder Equity Analysis

Total Current Liabilities vs Other Stockholder Equity

Total Current Liabilities vs Other Stockholder Equity Correlation Analysis

Correlation Coefficient

Total Current Liabilities

Other Stockholder Equity

Science Applications fundamental ratios Correlations

Science Applications Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Science Applications fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Science Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Non Current Liabilities Total	+ 0.99	Short Long Term Debt Total
Intangible Assets	+ 0.99	Net Debt
Good Will	+ 0.99	Non Current Assets Total
Total Liab	+ 0.98	Total Assets
Total Current Assets	+ 0.98	Net Receivables

Inventory	- 0.52	Non Currrent Assets Other
Cash And Short Term Investments	- 0.46	Net Debt
Cash	- 0.46	Net Debt
Intangible Assets	- 0.42	Cash And Short Term Investments
Intangible Assets	- 0.42	Cash
Net Debt	- 0.38	Common Stock Shares Outstanding